Efficacy of MMR vaccine in warts
Phase 2
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2018/10/016238
- Lead Sponsor
- self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
cases with multiple Common warts(more than 5 warts at single anatomical site or 1 or more warts at more than 2 anatomical sites who did recieve any treatment for warts in last 2 weeks
Exclusion Criteria
1 Cases with verruca plana or anogenital warts
2 Females of child bearing potential
3 Cases with systemic or other cutaneous disease
4 Immunocompromised cases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method